Village Caregiving reports that frontotemporal dementia is a progressive brain disease affecting behavior, speech, and memory ...
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the ...
Advanced MRI detects early frontotemporal dementia microstructural damage, enabling earlier diagnosis and monitoring of disease progression.
Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; ...
In the wake of Bruce Willis' diagnosis, Emma Heming has taken to social media to raise awareness about FTD, a type of dementia that affects behavior, personality, and language. Through her heartfelt ...
An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...
A new international study led by researchers at Karolinska Institutet demonstrates that it is possible to detect subtle ...